Literature DB >> 7527595

Pharmacologic management of cancer pain.

M H Levy1.   

Abstract

The ideal goal of cancer pain management is the combination of comfort and function. For the vast majority of cancer pain patients, this balance can be achieved with individually titrated opioid analgesics and specifically prescribed coanalgesics. Integration of pain blocking procedures and cognitive behavioral therapies can further enhance the quality of life of selected patients. Comprehensive cancer pain management should be offered in concert with anticancer therapy and shares many of its constructs: prevention, early detection, specific therapy, combination chemotherapy, dose intensity, combined modalities, and psychosocial support. Unlike the control of cancer, the tools to effectively control cancer pain are readily available. Their use takes time, skill, and commitment and should be the very least that is provided to all cancer patients and their families.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527595

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  4 in total

Review 1.  Management of common symptoms of advanced lung cancer.

Authors:  Michelle Bedor; Carla Alexander; Martin J Edelman
Journal:  Curr Treat Options Oncol       Date:  2005-01

Review 2.  Emergency orthogeriatrics: concepts and therapeutic alternatives.

Authors:  Christopher R Carpenter; Michael E Stern
Journal:  Emerg Med Clin North Am       Date:  2010-11       Impact factor: 2.264

Review 3.  Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions.

Authors:  J A Balfour; A Fitton; L B Barradell
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 4.  Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.

Authors:  Gustavo A Angarita; Nazli Emadi; Sarah Hodges; Peter T Morgan
Journal:  Addict Sci Clin Pract       Date:  2016-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.